Stocks Analyzed: Recommendations from Kotak Securities

This report analyzes two stock recommendations from Kotak Securities: Union Bank of India and Apollo Hospitals Enterprise. The goal is to provide actionable insights for both executives and investors seeking to understand the financial health and future potential of these companies.

Key Points

• Union Bank: Strong asset quality improving, leading to higher profits.
• Union Bank: Stable margins and a large recovery pipeline boost earnings prospects.
• Union Bank: Attractive valuation at current levels (1.0x FY26E book value).
• Apollo Hospitals: Well-diversified healthcare group with limited NCR exposure.
• Apollo Hospitals: Strategic acquisition of IFC’s stake strengthens Apollo Health & Lifestyle.
• Apollo Hospitals: Ambitious revenue growth targets in oncology, supported by new Proton therapy centers.

Union Bank of India is showing signs of improvement. The bank’s asset quality is strengthening, leading to higher profits. This is reflected in metrics like declining non-performing assets and a robust provision coverage ratio. The bank is focusing on lending to retail, agriculture, and MSMEs, which are growing faster than traditional corporate loans, and this is contributing to improved profitability.

Kotak Securities recommends buying Union Bank at a current market price of ₹146, as the stock trades attractively. This recommendation is based on the bank’s strong financial performance and future growth potential.

Apollo Hospitals Enterprise is another recommended stock. The company boasts a diversified healthcare group with a significant presence across India, but notably avoids the intensely competitive Delhi-NCR region. This focus on stable regional growth is a key factor in their strategy. The acquisition of IFC’s stake in Apollo Health & Lifestyle, coupled with planned demergers, are streamlining the organization.

Apollo’s ambitions extend to significantly growing its oncology revenue – aiming for over ₹5,000 crore in the next 3-4 years. This growth will be fueled by expanding Proton therapy centers and strategic corporate tie-ups. These ambitious goals suggest a strong belief in the rising demand for advanced cancer care within India.

Finally, Apollo’s financial position is robust, fueled by strong cash flow and improving pharmacy business margins. While the digital platform recovery is expected by FY26, management’s focus on cost efficiency and corporate partnerships offers a clear path to profitability.

“Investments in Union Bank and Apollo Hospitals are strategic plays for sustainable growth and significant returns.”